Representative Jefferson Shreve (R-Indiana) recently bought shares of MicroStrategy Incorporated NASDAQ: MSTR. In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in MicroStrategy stock on February 24th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.
Representative Jefferson Shreve also recently made the following trade(s):
- Purchased $15,001 - $50,000 in shares of RTX NYSE: RTX on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Royal Gold NASDAQ: RGLD on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of QUALCOMM NASDAQ: QCOM on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 2/24/2025.
- Sold $15,001 - $50,000 in shares of Norfolk Southern NYSE: NSC on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of CoStar Group NASDAQ: CSGP on 2/24/2025.
- Purchased $50,001 - $100,000 in shares of AbbVie NYSE: ABBV on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Johnson & Johnson NYSE: JNJ on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of The Cigna Group NYSE: CI on 2/24/2025.
- Purchased $15,001 - $50,000 in shares of Adobe NASDAQ: ADBE on 2/24/2025.
MicroStrategy Stock Performance
Shares of MSTR stock traded up $1.96 during trading on Wednesday, hitting $262.55. The company's stock had a trading volume of 14,193,364 shares, compared to its average volume of 18,770,730. The company has a current ratio of 0.71, a quick ratio of 0.65 and a debt-to-equity ratio of 0.39. The company has a market cap of $67.57 billion, a PE ratio of -46.61 and a beta of 3.36. The business has a fifty day moving average of $323.71 and a 200-day moving average of $280.20. MicroStrategy Incorporated has a 52 week low of $101.00 and a 52 week high of $543.00.
MicroStrategy (NASDAQ:MSTR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The software maker reported ($3.20) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($3.07). MicroStrategy had a negative return on equity of 19.01% and a negative net margin of 251.73%.
Hedge Funds Weigh In On MicroStrategy
Institutional investors have recently modified their holdings of the company. Riverview Trust Co purchased a new position in MicroStrategy in the 4th quarter worth $25,000. IAG Wealth Partners LLC bought a new position in shares of MicroStrategy during the fourth quarter valued at approximately $25,000. Quadrant Capital Group LLC boosted its holdings in MicroStrategy by 855.6% in the fourth quarter. Quadrant Capital Group LLC now owns 86 shares of the software maker's stock valued at $25,000 after acquiring an additional 77 shares in the last quarter. Dunhill Financial LLC purchased a new position in MicroStrategy during the 4th quarter valued at $26,000. Finally, Capital Performance Advisors LLP bought a new position in MicroStrategy in the 3rd quarter worth $27,000. 59.84% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
MSTR has been the subject of a number of research reports. Compass Point upgraded shares of MicroStrategy to a "strong-buy" rating in a research report on Wednesday, January 29th. Sanford C. Bernstein restated an "outperform" rating and set a $600.00 target price on shares of MicroStrategy in a research report on Thursday, December 12th. Cantor Fitzgerald lifted their price target on MicroStrategy from $613.00 to $619.00 and gave the company an "overweight" rating in a research report on Thursday, February 6th. Keefe, Bruyette & Woods started coverage on MicroStrategy in a research note on Friday, February 7th. They issued an "outperform" rating and a $560.00 target price for the company. Finally, Benchmark reissued a "buy" rating and issued a $650.00 price target on shares of MicroStrategy in a report on Tuesday, January 14th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $536.90.
Check Out Our Latest Stock Report on MSTR
About Representative Shreve
Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election.
Email editor@ballotpedia.org to notify us of updates to this biography.
Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive.
Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.
MicroStrategy Company Profile
(
Get Free Report)
MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions.
Recommended Stories
Before you consider MicroStrategy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MicroStrategy wasn't on the list.
While MicroStrategy currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.